(Q48423645)

11 February 2018

title

Imaging response criteria for recurrent gliomas treated with bevacizumab: role of diffusion weighted imaging as an imaging biomarker. (English)

1 reference

11 February 2018

0 references

1 reference

7

Tom Mikkelsen

1 reference

11 February 2018

author name string

Rajan Jain

1

1 reference

11 February 2018

Lisa M Scarpace

2

1 reference

11 February 2018

Shehanaz Ellika

3

1 reference

11 February 2018

Roy Torcuator

4

1 reference

11 February 2018

Lonni R Schultz

5

1 reference

11 February 2018

David Hearshen

6

1 reference

11 February 2018

publication date

27 October 2009

1 reference

11 February 2018

Journal of Neuro-Oncology

published in

1 reference

11 February 2018

volume

96

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

423-431

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/s11060-009-9981-6

exact match

0 references

cites work

MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-009-9981-6

MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-009-9981-6

High-grade glioma before and after treatment with radiation and Avastin: initial observations

21 January 2018

1 reference

12 December 2020

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

12 December 2020

Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2.

1 reference

12 December 2020

Inverse correlation between choline magnetic resonance spectroscopy signal intensity and the apparent diffusion coefficient in human glioma

1 reference

12 December 2020

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

12 December 2020

Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence

1 reference

12 December 2020

Time course of imaging changes of GBM during extended bevacizumab treatment

1 reference

12 December 2020

Response criteria for glioma

1 reference

12 December 2020

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

1 reference

12 December 2020

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

1 reference

12 December 2020

MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy.

1 reference

12 December 2020

Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma.

1 reference

12 December 2020

Reporting results of cancer treatment

1 reference

12 December 2020

Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption

1 reference

12 December 2020

The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome

1 reference

12 December 2020

Role of diffusion-weighted echo-planar MRI in distinguishing between brain brain abscess and tumour: a preliminary report.

1 reference

12 December 2020

In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres

1 reference

12 December 2020

Brain tumor imaging in clinical trials

1 reference

12 December 2020

10.1007/S11060-009-9981-6

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018